Medications

Health care M&A leads global deal surge

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...

HIV & AIDS

Protection against HSV-2 is added benefit of tenofovir

(HealthDay)—Tenofovir for HIV-1 preexposure prophylaxis (PrEP) provides the added benefit of protection against herpes simplex virus type 2 (HSV-2) acquisition, according to a study published in the July 1 issue of the ...

HIV & AIDS

HIV vaccine research must consider various immune responses

Last year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, held a scientific meeting to examine why certain investigational HIV vaccines may have increased susceptibility ...

Medications

US drugs firm Mylan completes $1.75 bln India buyout

US generic drug specialist Mylan said Thursday it had completed its $1.75 billion acquisition of a unit of India's Strides Arcolab, boosting its presence in the high-growth injectable drugs market.

Medications

Sanofi looking at 1-2 bn euros of acquisitions per year

French pharmaceutical group Sanofi is looking to make annual acquisitions of up to two billion euros to boost its priority sectors, managing director Chris Viehbacher told Monday's Le Figaro newspaper.

Psychology & Psychiatry

Study finds potential key to learning a new language

A new study by University of Houston (UH) researchers may lead to dramatic changes in the way language is taught and learned – especially a second language. These findings are important because statistics show 60 percent ...

page 7 from 13